Vimarsana
Biggest News Aggregation in the World

Page 5 - Spin Offs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spin Offs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spin Offs Today - Breaking & Trending Today

Transcripts For BBCNEWS Breakfast - Vimarsana News

Transcripts For BBCNEWS Breakfast

burns in a fire that killed his younger brother, raises money for the charity that got him back on his feet. the future ofjohn lewis and the high street — are there big closures coming for one of the biggest name in retail? how are town centres coping with our new shopping habits? good morning. liverpool march on in europe — they brush aside their troubles at home in the premier league, to reach the quarter—finals of the champions league. and did the winds were regular slide? wales had its strongest wind gust since february last year. details on breakfast. good morning. it's th...

Pfizer (PFE) earnings Q1 2024 - Vimarsana News

Pfizer (PFE) earnings Q1 2024

The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral pill Paxlovid.

Source: cnbc.com
3G Capital quietly exited its Kraft Heinz investment last year - Vimarsana News

3G Capital quietly exited its Kraft Heinz investment last year

3G Capital, which helped to engineer the Kraft Heinz merger, had seen its influence at the company wane.

Source: cnbc.com
Match adds two directors in deal with activist investor - Vimarsana News

Match adds two directors in deal with activist investor

Match announced an information-sharing agreement with Elliott Management and added an Instacart executive and a Zillow co-founder to its board.

Source: cnbc.com
Pfizer (PFE) Q4 earnings report 2023 - Vimarsana News

Pfizer (PFE) Q4 earnings report 2023

Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government. 

Source: cnbc.com